[1]
Ayutri, M., Andrajati, R. and Subhan, A. 2022. EVALUATION OF OSELTAMIVIR AND FAVIPIRAVIR ON CLINICAL OUTCOMES AND LENGTH OF STAY IN COVID-19 PATIENTS AT FATMAWATI GENERAL HOSPITAL JAKARTA. Asian Journal of Pharmaceutical and Clinical Research. 15, 10 (Oct. 2022), 84–86. DOI:https://doi.org/10.22159/ajpcr.2022.v15i10.45801.